TreeWAS – Variant ID: rs7523050

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
T36-T50 Poisoning by drugs, medicaments and biological substances	0.575	0.425	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.571	0.429	0.000
T39.1 4-Aminophenol derivatives	0.566	0.434	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.561	0.439	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.532	0.468	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.532	0.468	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.528	0.472	0.000
T36 Poisoning by systemic antibiotics	0.528	0.472	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.526	0.474	0.000
T42.4 Benzodiazepines	0.511	0.489	0.000
T40.2 Other opioids	0.496	0.504	0.000
T36.0 Penicillins	0.493	0.507	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.469	0.530	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.464	0.536	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.456	0.544	0.000
T43.6 Psychostimulants with abuse potential	0.442	0.557	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.434	0.566	0.000
T42.0 Hydantoin derivatives	0.420	0.580	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.420	0.580	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.413	0.587	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.412	0.587	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.412	0.587	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.412	0.587	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.412	0.587	0.000
T39.4 Antirheumatics, not elsewhere classified	0.410	0.590	0.000
T39.2 Pyrazolone derivatives	0.410	0.590	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.402	0.597	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.402	0.597	0.000
T42.3 Barbiturates	0.402	0.597	0.000
T42.2 Succinimides and oxazolidinediones	0.402	0.597	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.388	0.612	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.385	0.615	0.000
T42.1 Iminostilbenes	0.384	0.616	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.382	0.617	0.000
T43.9 Psychotropic drug, unspecified	0.381	0.619	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.381	0.619	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.381	0.619	0.000
T40.6 Other and unspecified narcotics	0.381	0.619	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.378	0.621	0.000
T40.8 Lysergide [LSD]	0.378	0.621	0.000
T40.7 Cannabis (derivatives)	0.378	0.621	0.000
T40.5 Cocaine	0.378	0.621	0.000
T40.3 Methadone	0.378	0.621	0.000
T40.1 Heroin	0.378	0.621	0.000
T40.0 Opium	0.378	0.621	0.000
T36.9 Systemic antibiotic, unspecified	0.378	0.622	0.000
T36.8 Other systemic antibiotics	0.378	0.622	0.000
T36.7 Antifungal antibiotics, systemically used	0.378	0.622	0.000
T36.6 Rifamycins	0.378	0.622	0.000
T36.5 Aminoglycosides	0.378	0.622	0.000
T36.4 Tetracyclines	0.378	0.622	0.000
T36.3 Macrolides	0.378	0.622	0.000
T36.2 Chloramphenicol group	0.378	0.622	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.378	0.622	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.378	0.622	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.370	0.630	0.000
T43.2 Other and unspecified antidepressants	0.367	0.633	0.000
T40.4 Other synthetic narcotics	0.366	0.634	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.361	0.638	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.350	0.650	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.340	0.660	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.333	0.667	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.333	0.667	0.000
T47.7 Emetics	0.333	0.667	0.000
T47.6 Antidiarrhoeal drugs	0.333	0.667	0.000
T47.5 Digestants	0.333	0.667	0.000
T47.4 Other laxatives	0.333	0.667	0.000
T47.3 Saline and osmotic laxatives	0.333	0.667	0.000
T47.2 Stimulant laxatives	0.333	0.667	0.000
T47.0 Histamine H(2)-receptor antagonists	0.333	0.667	0.000
T38.1 Thyroid hormones and substitutes	0.331	0.669	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.328	0.672	0.000
T50.8 Diagnostic agents	0.327	0.673	0.000
T50.7 Analeptics and opioid receptor antagonists	0.327	0.673	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.327	0.673	0.000
T50.5 Appetite depressants	0.327	0.673	0.000
T50.4 Drugs affecting uric acid metabolism	0.327	0.673	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.327	0.673	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.327	0.673	0.000
T50.1 Loop [high-ceiling] diuretics	0.327	0.673	0.000
T50.0 Mineralocorticoids and their antagonists	0.327	0.673	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.315	0.685	0.000
T38.9 Other and unspecified hormone antagonists	0.301	0.699	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.301	0.699	0.000
T38.7 Androgens and anabolic congeners	0.301	0.699	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.301	0.699	0.000
T38.5 Other oestrogens and progestogens	0.301	0.699	0.000
T38.4 Oral contraceptives	0.301	0.699	0.000
T38.2 Antithyroid drugs	0.301	0.699	0.000
T38.0 Glucocorticoids and synthetic analogues	0.301	0.699	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.296	0.704	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.296	0.704	0.000
T37.5 Antiviral drugs	0.296	0.704	0.000
T37.4 Anthelminthics	0.296	0.704	0.000
T37.3 Other antiprotozoal drugs	0.296	0.704	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.296	0.704	0.000
T37.1 Antimycobacterial drugs	0.296	0.704	0.000
T37.0 Sulphonamides	0.296	0.704	0.000
T41.5 Therapeutic gases	0.296	0.704	0.000
T41.4 Anaesthetic, unspecified	0.296	0.704	0.000
T41.3 Local anaesthetics	0.296	0.704	0.000
T41.2 Other and unspecified general anaesthetics	0.296	0.704	0.000
T41.1 Intravenous anaesthetics	0.296	0.704	0.000
T41.0 Inhaled anaesthetics	0.296	0.704	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.296	0.704	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.296	0.704	0.000
T48.5 Anti-common-cold drugs	0.296	0.704	0.000
T48.4 Expectorants	0.296	0.704	0.000
T48.3 Antitussives	0.296	0.704	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.296	0.704	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.296	0.704	0.000
T48.0 Oxytocic drugs	0.296	0.704	0.000
T49.9 Topical agent, unspecified	0.296	0.704	0.000
T49.8 Other topical agents	0.296	0.704	0.000
T49.7 Dental drugs, topically applied	0.296	0.704	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.296	0.704	0.000
T49.5 Ophthalmological drugs and preparations	0.296	0.704	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.296	0.704	0.000
T49.3 Emollients, demulcents and protectants	0.296	0.704	0.000
T49.2 Local astringents and local detergents	0.296	0.704	0.000
T49.1 Antipruritics	0.296	0.704	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.296	0.704	0.000
T39.0 Salicylates	0.294	0.706	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.272	0.728	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.271	0.729	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.271	0.729	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.271	0.729	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.271	0.729	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.271	0.729	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.271	0.729	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.271	0.729	0.000
T44.0 Anticholinesterase agents	0.271	0.729	0.000
T45.2 Vitamins, not elsewhere classified	0.249	0.751	0.000
T45.0 Antiallergic and antiemetic drugs	0.248	0.752	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.244	0.756	0.000
T45.8 Other primarily systemic and haematological agents	0.244	0.756	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.244	0.756	0.000
T45.6 Fibrinolysis-affecting drugs	0.244	0.756	0.000
T45.4 Iron and its compounds	0.244	0.756	0.000
T45.3 Enzymes, not elsewhere classified	0.244	0.756	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.241	0.759	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.235	0.764	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.235	0.764	0.000
T46.7 Peripheral vasodilators	0.235	0.764	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.235	0.764	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.235	0.764	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.235	0.764	0.000
T46.1 Calcium-channel blockers	0.224	0.776	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.218	0.782	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.212	0.788	0.000
T45.5 Anticoagulants	0.199	0.801	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.187	0.813	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.138	0.862	0.001
I12.0 Hypertensive renal disease with renal failure	0.000	0.886	0.114
I12 Hypertensive renal disease	0.000	0.943	0.057
I12.9 Hypertensive renal disease without renal failure	0.000	0.956	0.044
L85.8 Other specified epidermal thickening	0.000	0.990	0.010
K75.4 Autoimmune hepatitis	0.000	0.991	0.009
K75 Other inflammatory liver diseases	0.000	0.991	0.009
K75.9 Inflammatory liver disease, unspecified	0.000	0.991	0.009
K75.8 Other specified inflammatory liver diseases	0.000	0.991	0.009
I10-I15 Hypertensive diseases	0.000	0.992	0.008
K75.0 Abscess of liver	0.000	0.992	0.008
K75.2 Nonspecific reactive hepatitis	0.000	0.993	0.006
K75.1 Phlebitis of portal vein	0.000	0.993	0.006
O20.9 Haemorrhage in early pregnancy, unspecified	0.000	0.994	0.006
I13 Hypertensive heart and renal disease	0.000	0.994	0.006
C79.8 Secondary malignant neoplasm of other specified sites	0.006	0.994	0.000
I11 Hypertensive heart disease	0.000	0.994	0.006
Z99.2 Dependence on renal dialysis	0.000	0.994	0.006
K75.3 Granulomatous hepatitis, not elsewhere classified	0.000	0.994	0.005
I15 Secondary hypertension	0.000	0.994	0.006
N18.0 End-stage renal disease	0.000	0.995	0.005
C78.1 Secondary malignant neoplasm of mediastinum	0.005	0.995	0.000
C09.9 Tonsil, unspecified	0.005	0.995	0.000
I11.9 Hypertensive heart disease without (congestive) heart failure	0.000	0.995	0.005
I13.9 Hypertensive heart and renal disease, unspecified	0.000	0.995	0.004
I13.2 Hypertensive heart and renal disease with both (congestive) heart failure and renal failure	0.000	0.995	0.004
I13.1 Hypertensive heart and renal disease with renal failure	0.000	0.995	0.004
I13.0 Hypertensive heart and renal disease with (congestive) heart failure	0.000	0.995	0.004
C09 Malignant neoplasm of tonsil	0.004	0.996	0.000
I15.8 Other secondary hypertension	0.000	0.996	0.004
I15.2 Hypertension secondary to endocrine disorders	0.000	0.996	0.004
I15.0 Renovascular hypertension	0.000	0.996	0.004
I15.9 Seconday hypertension, unspecified	0.000	0.996	0.004
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.004	0.996	0.000
C78.4 Secondary malignant neoplasm of small intestine	0.004	0.996	0.000
C78 Secondary malignant neoplasm of respiratory and digestive organs	0.004	0.996	0.000
L02.2 Cutaneous abscess, furuncle and carbuncle of trunk	0.004	0.996	0.000
C78.2 Secondary malignant neoplasm of pleura	0.004	0.996	0.000
C10 Malignant neoplasm of oropharynx	0.004	0.996	0.000
C10.9 Oropharynx, unspecified	0.004	0.996	0.000
I15.1 Hypertension secondary to other renal disorders	0.000	0.996	0.004
I11.0 Hypertensive heart disease with (congestive) heart failure	0.000	0.996	0.004
C06 Malignant neoplasm of other and unspecified parts of mouth	0.004	0.996	0.000
C07 Malignant neoplasm of parotid gland	0.004	0.996	0.000
O20 Haemorrhage in early pregnancy	0.000	0.996	0.004
C01 Malignant neoplasm of base of tongue	0.004	0.996	0.000
C05 Malignant neoplasm of palate	0.004	0.996	0.000
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs	0.004	0.996	0.000
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx	0.003	0.996	0.000
C08 Malignant neoplasm of other and unspecified major salivary glands	0.003	0.996	0.000
C78.7 Secondary malignant neoplasm of liver	0.004	0.996	0.000
L90.0 Lichen sclerosus et atrophicus	0.000	0.996	0.003
M79.62 Pain in limb (Upper arm)	0.004	0.996	0.000
I67.9 Cerebrovascular disease, unspecified	0.003	0.997	0.000
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum	0.003	0.997	0.000
C09.8 Overlapping lesion of tonsil	0.003	0.997	0.000
C09.1 Tonsillar pillar (anterior) (posterior)	0.003	0.997	0.000
C09.0 Tonsillar fossa	0.003	0.997	0.000
C03 Malignant neoplasm of gum	0.003	0.997	0.000
N48.8 Other specified disorders of penis	0.000	0.997	0.003
C13 Malignant neoplasm of hypopharynx	0.003	0.997	0.000
C00 Malignant neoplasm of lip	0.003	0.997	0.000
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs	0.003	0.997	0.000
C11 Malignant neoplasm of nasopharynx	0.003	0.997	0.000
C02 Malignant neoplasm of other and unspecified parts of tongue	0.003	0.997	0.000
O20.0 Threatened abortion	0.000	0.997	0.003
C04 Malignant neoplasm of floor of mouth	0.003	0.997	0.000
C05.1 Soft palate	0.003	0.997	0.000
C10.8 Overlapping lesion of oropharynx	0.003	0.997	0.000
C10.4 Branchial cleft	0.003	0.997	0.000
C10.3 Posterior wall of oropharynx	0.003	0.997	0.000
C10.2 Lateral wall of oropharynx	0.003	0.997	0.000
C10.1 Anterior surface of epiglottis	0.003	0.997	0.000
C10.0 Vallecula	0.003	0.997	0.000
F32.1 Moderate depressive episode	0.003	0.997	0.000
Z91.5 Personal history of self-harm	0.003	0.997	0.000
C06.9 Mouth, unspecified	0.003	0.997	0.000
E11.4 With neurological complications	0.000	0.997	0.003
C06.0 Cheek mucosa	0.003	0.997	0.000
A41.9 Septicaemia, unspecified	0.003	0.997	0.000
C06.2 Retromolar area	0.003	0.997	0.000
C14.0 Pharynx, unspecified	0.003	0.997	0.000
Y57.9 Drug or medicament, unspecified	0.003	0.997	0.000
C08.0 Submandibular gland	0.003	0.997	0.000
E16.2 Hypoglycaemia, unspecified	0.000	0.997	0.003
C02.9 Tongue, unspecified	0.003	0.997	0.000
C06.8 Overlapping lesion of other and unspecified parts of mouth	0.003	0.997	0.000
C06.1 Vestibule of mouth	0.003	0.997	0.000
F32.2 Severe depressive episode without psychotic symptoms	0.003	0.997	0.000
L85 Other epidermal thickening	0.000	0.997	0.003
C12 Malignant neoplasm of pyriform sinus	0.003	0.997	0.000
Z99 Dependence on enabling machines and devices, not elsewhere classified	0.000	0.997	0.003
C05.9 Palate, unspecified	0.003	0.997	0.000
C05.8 Overlapping lesion of palate	0.003	0.997	0.000
C05.2 Uvula	0.003	0.997	0.000
C05.0 Hard palate	0.003	0.997	0.000
C08.9 Major salivary gland, unspecified	0.003	0.997	0.000
C67.2 Lateral wall of bladder	0.000	0.997	0.003
O20.8 Other haemorrhage in early pregnancy	0.000	0.997	0.003
F32 Depressive episode	0.003	0.997	0.000
C08.8 Overlapping lesion of major salivary glands	0.003	0.997	0.000
C08.1 Sublingual gland	0.003	0.997	0.000
C14.8 Overlapping lesion of lip, oral cavity and pharynx	0.003	0.997	0.000
C14.2 Waldeyer's ring	0.003	0.997	0.000
C03.1 Lower gum	0.003	0.997	0.000
E11.6 With other specified complications	0.000	0.997	0.003
E11.8 With unspecified complications	0.000	0.997	0.003
S51.0 Open wound of elbow	0.003	0.997	0.000
Z99.3 Dependence on wheelchair	0.000	0.997	0.003
F30 Manic episode	0.003	0.997	0.000
C03.9 Gum, unspecified	0.003	0.997	0.000
C03.0 Upper gum	0.003	0.997	0.000
E11.3 With ophthalmic complications	0.000	0.997	0.003
E11 Non-insulin-dependent diabetes mellitus	0.000	0.997	0.003
C00.9 Lip, unspecified	0.002	0.997	0.000
C00.8 Overlapping lesion of lip	0.002	0.997	0.000
C00.6 Commissure of lip	0.002	0.997	0.000
C00.5 Lip, unspecified, inner aspect	0.002	0.997	0.000
C00.4 Lower lip, inner aspect	0.002	0.997	0.000
C00.3 Upper lip, inner aspect	0.002	0.997	0.000
C00.2 External lip, unspecified	0.002	0.997	0.000
C00.1 External lower lip	0.002	0.997	0.000
C00.0 External upper lip	0.002	0.997	0.000
C13.9 Hypopharynx, unspecified	0.002	0.997	0.000
C13.8 Overlapping lesion of hypopharynx	0.002	0.997	0.000
C13.2 Posterior wall of hypopharynx	0.002	0.997	0.000
C13.1 Aryepiglottic fold, hypopharyngeal aspect	0.002	0.997	0.000
C13.0 Postcricoid region	0.002	0.997	0.000
C11.8 Overlapping lesion of nasopharynx	0.002	0.997	0.000
C11.3 Anterior wall of nasopharynx	0.002	0.997	0.000
C11.2 Lateral wall of nasopharynx	0.002	0.997	0.000
C11.1 Posterior wall of nasopharynx	0.002	0.997	0.000
C11.0 Superior wall of nasopharynx	0.002	0.997	0.000
Z99.8 Dependence on other enabling machines and devices	0.000	0.997	0.003
C02.8 Overlapping lesion of tongue	0.002	0.997	0.000
C02.4 Lingual tonsil	0.002	0.997	0.000
C02.3 Anterior two-thirds of tongue, part unspecified	0.002	0.997	0.000
C02.2 Ventral surface of tongue	0.002	0.997	0.000
C02.0 Dorsal surface of tongue	0.002	0.997	0.000
C11.9 Nasopharynx, unspecified	0.002	0.997	0.000
F32.8 Other depressive episodes	0.003	0.997	0.000
C79 Secondary malignant neoplasm of other sites	0.003	0.997	0.000
C04.8 Overlapping lesion of floor of mouth	0.002	0.997	0.000
C04.1 Lateral floor of mouth	0.002	0.997	0.000
C04.0 Anterior floor of mouth	0.002	0.997	0.000
F30.1 Mania without psychotic symptoms	0.003	0.997	0.000
F30.0 Hypomania	0.003	0.997	0.000
N48.0 Leukoplakia of penis	0.000	0.997	0.003
A41.1 Septicaemia due to other specified staphylococcus	0.003	0.997	0.000
F25.9 Schizoaffective disorder, unspecified	0.003	0.997	0.000
B96.2 Escherichia coli [E. coli] as the cause of diseases classified to other chapters	0.000	0.997	0.003
C04.9 Floor of mouth, unspecified	0.002	0.997	0.000
E11.1 With ketoacidosis	0.000	0.997	0.003
C67.9 Bladder, unspecified	0.000	0.997	0.003
C79.0 Secondary malignant neoplasm of kidney and renal pelvis	0.002	0.997	0.000
F30.2 Mania with psychotic symptoms	0.002	0.997	0.000
F25 Schizoaffective disorders	0.002	0.997	0.000
C67.5 Bladder neck	0.000	0.998	0.002
F01.9 Vascular dementia, unspecified	0.002	0.998	0.000
C76.0 Head, face and neck	0.002	0.998	0.000
L85.1 Acquired keratosis [keratoderma] palmaris et plantaris	0.000	0.998	0.002
L85.3 Xerosis cutis	0.000	0.998	0.002
L85.2 Keratosis punctata (palmaris et plantaris)	0.000	0.998	0.002
L85.0 Acquired ichthyosis	0.000	0.998	0.002
Z99.9 Dependence on unspecified enabling machine and device	0.000	0.998	0.002
Z99.4 Dependence on artificial heart	0.000	0.998	0.002
Z99.0 Dependence on aspirator	0.000	0.998	0.002
C76 Malignant neoplasm of other and ill-defined sites	0.002	0.998	0.000
C67 Malignant neoplasm of bladder	0.000	0.998	0.002
F20-F29 Schizophrenia, schizotypal and delusional disorders	0.002	0.998	0.000
D37.7 Other digestive organs	0.002	0.998	0.000
M80.90 Unspecified osteoporosis with pathological fracture (Multiple sites)	0.000	0.998	0.002
N48 Other disorders of penis	0.000	0.998	0.002
F30-F39 Mood [affective] disorders	0.002	0.998	0.000
J84.1 Other interstitial pulmonary diseases with fibrosis	0.000	0.998	0.002
F22 Persistent delusional disorders	0.002	0.998	0.000
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites	0.002	0.998	0.000
F32.3 Severe depressive episode with psychotic symptoms	0.002	0.998	0.000
F34 Persistent mood [affective] disorders	0.002	0.998	0.000
F30.8 Other manic episodes	0.002	0.998	0.000
F34.1 Dysthymia	0.002	0.998	0.000
C79.3 Secondary malignant neoplasm of brain and cerebral meninges	0.002	0.998	0.000
E11.2 With renal complications	0.000	0.998	0.002
E11.7 With multiple complications	0.000	0.998	0.002
F30.9 Manic episode, unspecified	0.002	0.998	0.000
N48.1 Balanoposthitis	0.000	0.998	0.002
A41 Other septicaemia	0.002	0.998	0.000
F60 Specific personality disorders	0.002	0.998	0.000
C79.5 Secondary malignant neoplasm of bone and bone marrow	0.002	0.998	0.000
F22.0 Delusional disorder	0.002	0.998	0.000
O70.9 Perineal laceration during delivery, unspecified	0.002	0.998	0.000
N48.9 Disorder of penis, unspecified	0.000	0.998	0.002
D16.3 Short bones of lower limb	0.002	0.998	0.000
F25.0 Schizoaffective disorder, manic type	0.002	0.998	0.000
S51.9 Open wound of forearm, part unspecified	0.002	0.998	0.000
Y57 Other and unspecified drugs and medicaments	0.002	0.998	0.000
F23 Acute and transient psychotic disorders	0.002	0.998	0.000
C78.5 Secondary malignant neoplasm of large intestine and rectum	0.002	0.998	0.000
F25.1 Schizoaffective disorder, depressive type	0.002	0.998	0.000
F60.3 Emotionally unstable personality disorder	0.002	0.998	0.000
F60.0 Paranoid personality disorder	0.002	0.998	0.000
C02.1 Border of tongue	0.002	0.998	0.000
C76.2 Abdomen	0.002	0.998	0.000
K76.9 Liver disease, unspecified	0.000	0.998	0.002
C79.2 Secondary malignant neoplasm of skin	0.002	0.998	0.000
F22.9 Persistent delusional disorder, unspecified	0.002	0.998	0.000
F25.8 Other schizoaffective disorders	0.002	0.998	0.000
F25.2 Schizoaffective disorder, mixed type	0.002	0.998	0.000
C67.1 Dome of bladder	0.000	0.998	0.002
Y57.8 Other drugs and medicaments	0.002	0.998	0.000
F29 Unspecified nonorganic psychosis	0.002	0.998	0.000
F60-F69 Disorders of adult personality and behaviour	0.002	0.998	0.000
E11.5 With peripheral circulatory complications	0.000	0.998	0.002
A41.2 Septicaemia due to unspecified staphylococcus	0.002	0.998	0.000
K58.0 Irritable bowel syndrome with diarrhoea	0.000	0.998	0.002
Y57.6 Other diagnostic agents	0.002	0.998	0.000
C67.8 Overlapping lesion of bladder	0.000	0.998	0.002
M80.98 Unspecified osteoporosis with pathological fracture (Other)	0.000	0.998	0.002
C76.8 Overlapping lesion of other and ill-defined sites	0.002	0.998	0.000
C76.7 Other ill-defined sites	0.002	0.998	0.000
C76.5 Lower limb	0.002	0.998	0.000
C76.4 Upper limb	0.002	0.998	0.000
C76.3 Pelvis	0.002	0.998	0.000
C76.1 Thorax	0.002	0.998	0.000
F10.0 Acute intoxication	0.002	0.998	0.000
T93.2 Sequelae of other fractures of lower limb	0.000	0.998	0.002
C67.7 Urachus	0.000	0.998	0.002
C67.0 Trigone of bladder	0.000	0.998	0.002
F28 Other nonorganic psychotic disorders	0.002	0.998	0.000
F24 Induced delusional disorder	0.002	0.998	0.000
F21 Schizotypal disorder	0.002	0.998	0.000
M54.16 Radiculopathy (Lumbar region)	0.002	0.998	0.000
D11.0 Parotid gland	0.002	0.998	0.000
F22.8 Other persistent delusional disorders	0.002	0.998	0.000
F23.9 Acute and transient psychotic disorder, unspecified	0.002	0.998	0.000
N48.5 Ulcer of penis	0.000	0.998	0.002
R63.0 Anorexia	0.000	0.998	0.002
Z43.6 Attention to other artificial openings of urinary tract	0.002	0.998	0.000
F38 Other mood [affective] disorders	0.002	0.998	0.000
C67.4 Posterior wall of bladder	0.000	0.998	0.002
A41.0 Septicaemia due to Staphylococcus aureus	0.002	0.998	0.000
E07.9 Disorder of thyroid, unspecified	0.000	0.998	0.002
F32.9 Depressive episode, unspecified	0.002	0.998	0.000
F34.9 Persistent mood [affective] disorder, unspecified	0.002	0.998	0.000
F34.8 Other persistent mood [affective] disorders	0.002	0.998	0.000
F34.0 Cyclothymia	0.002	0.998	0.000
F60.9 Personality disorder, unspecified	0.002	0.998	0.000
N30.9 Cystitis, unspecified	0.002	0.998	0.000
F69 Unspecified disorder of adult personality and behaviour	0.002	0.998	0.000
A41.4 Septicaemia due to anaerobes	0.002	0.998	0.000
A41.3 Septicaemia due to Haemophilus influenzae	0.002	0.998	0.000
F60.8 Other specific personality disorders	0.002	0.998	0.000
F60.7 Dependent personality disorder	0.002	0.998	0.000
F60.6 Anxious [avoidant] personality disorder	0.002	0.998	0.000
F60.5 Anankastic personality disorder	0.002	0.998	0.000
F60.4 Histrionic personality disorder	0.002	0.998	0.000
F60.2 Dissocial personality disorder	0.002	0.998	0.000
F60.1 Schizoid personality disorder	0.002	0.998	0.000
F01 Vascular dementia	0.002	0.998	0.000
Chapter V Mental and behavioural disorders	0.002	0.998	0.000
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system	0.002	0.998	0.000
D36.1 Peripheral nerves and autonomic nervous system	0.000	0.998	0.002
S51 Open wound of forearm	0.002	0.998	0.000
M80.9 Unspecified osteoporosis with pathological fracture	0.000	0.998	0.002
N48.3 Priapism	0.000	0.998	0.002
Y57.7 Vitamins, not elsewhere classified	0.002	0.998	0.000
Y57.4 Pharmaceutical excipients	0.002	0.998	0.000
Y57.3 Alcohol deterrents	0.002	0.998	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.002	0.998	0.000
Y57.1 Lipotropic drugs	0.002	0.998	0.000
Y57.0 Appetite depressants [anorectics]	0.002	0.998	0.000
F23.8 Other acute and transient psychotic disorders	0.002	0.998	0.000
F23.3 Other acute predominantly delusional psychotic disorders	0.002	0.998	0.000
F23.2 Acute schizophrenia-like psychotic disorder	0.002	0.998	0.000
F23.1 Acute polymorphic psychotic disorder with symptoms of schizophrenia	0.002	0.998	0.000
F23.0 Acute polymorphic psychotic disorder without symptoms of schizophrenia	0.002	0.998	0.000
M67.8 Other specified disorders of synovium and tendon	0.000	0.998	0.002
N48.6 Balanitis xerotica obliterans	0.000	0.998	0.002
E16 Other disorders of pancreatic internal secretion	0.000	0.998	0.002
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)	0.000	0.998	0.002
L90.5 Scar conditions and fibrosis of skin	0.002	0.998	0.000
M10.96 Gout, unspecified (Lower leg)	0.000	0.998	0.002
F32.0 Mild depressive episode	0.002	0.998	0.000
F84.0 Childhood autism	0.002	0.998	0.000
X62.9 Unspecified place	0.002	0.998	0.000
C79.9 Secondary malignant neoplasm, unspecified site	0.002	0.998	0.000
N48.2 Other inflammatory disorders of penis	0.000	0.998	0.002
T51.0 Ethanol	0.002	0.998	0.000
F68 Other disorders of adult personality and behaviour	0.002	0.998	0.000
F66 Psychological and behavioural disorders associated with sexual development and orientation	0.002	0.998	0.000
F65 Disorders of sexual preference	0.002	0.998	0.000
F63 Habit and impulse disorders	0.002	0.998	0.000
F62 Enduring personality changes, not attributable to brain damage and disease	0.002	0.998	0.000
F61 Mixed and other personality disorders	0.002	0.998	0.000
F84 Pervasive developmental disorders	0.002	0.998	0.000
E11.0 With coma	0.000	0.998	0.002
K82.8 Other specified diseases of gallbladder	0.000	0.998	0.002
N19 Unspecified renal failure	0.000	0.998	0.002
M25.77 Osteophyte (Ankle and foot)	0.000	0.998	0.002
C67.3 Anterior wall of bladder	0.000	0.998	0.002
F41.0 Panic disorder [episodic paroxysmal anxiety]	0.002	0.998	0.000
C67.6 Ureteric orifice	0.000	0.998	0.002
J35.0 Chronic tonsillitis	0.000	0.998	0.002
R40.2 Coma, unspecified	0.000	0.998	0.002
F39 Unspecified mood [affective] disorder	0.002	0.998	0.000
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs	0.001	0.998	0.000
F38.8 Other specified mood [affective] disorders	0.001	0.998	0.000
F38.1 Other recurrent mood [affective] disorders	0.001	0.998	0.000
F38.0 Other single mood [affective] disorders	0.001	0.998	0.000
F84.5 Asperger's syndrome	0.002	0.998	0.000
F64 Gender identity disorders	0.002	0.998	0.000
H61.2 Impacted cerumen	0.000	0.998	0.002
R23.2 Flushing	0.002	0.998	0.000
Y57.5 X-ray contrast media	0.002	0.998	0.000
C79.7 Secondary malignant neoplasm of adrenal gland	0.002	0.998	0.000
C79.6 Secondary malignant neoplasm of ovary	0.001	0.998	0.000
F01.8 Other vascular dementia	0.001	0.998	0.000
F01.3 Mixed cortical and subcortical vascular dementia	0.001	0.998	0.000
F01.2 Subcortical vascular dementia	0.001	0.998	0.000
F01.1 Multi-infarct dementia	0.001	0.998	0.000
F01.0 Vascular dementia of acute onset	0.001	0.998	0.000
F20 Schizophrenia	0.002	0.998	0.000
F80-F89 Disorders of psychological development	0.002	0.998	0.000
F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence	0.001	0.998	0.000
F70-F79 Mental retardation	0.001	0.998	0.000
M80.97 Unspecified osteoporosis with pathological fracture (Ankle and foot)	0.000	0.998	0.001
M80.96 Unspecified osteoporosis with pathological fracture (Lower leg)	0.000	0.998	0.001
M80.95 Unspecified osteoporosis with pathological fracture (Pelvic region and thigh)	0.000	0.998	0.001
M80.94 Unspecified osteoporosis with pathological fracture (Hand)	0.000	0.998	0.001
M80.93 Unspecified osteoporosis with pathological fracture (Forearm)	0.000	0.998	0.001
M80.92 Unspecified osteoporosis with pathological fracture (Upper arm)	0.000	0.998	0.001
M80.91 Unspecified osteoporosis with pathological fracture (Shoulder region)	0.000	0.998	0.001
E16.9 Disorder of pancreatic internal secretion, unspecified	0.000	0.998	0.001
E16.8 Other specified disorders of pancreatic internal secretion	0.000	0.998	0.001
E16.4 Abnormal secretion of gastrin	0.000	0.998	0.001
E16.3 Increased secretion of glucagon	0.000	0.998	0.001
E16.1 Other hypoglycaemia	0.000	0.998	0.001
I34.1 Mitral (valve) prolapse	0.002	0.998	0.000
Z99.1 Dependence on respirator	0.000	0.998	0.002
M80.99 Unspecified osteoporosis with pathological fracture (Site unspecified)	0.000	0.998	0.001
F20.5 Residual schizophrenia	0.001	0.998	0.000
T83.1 Mechanical complication of other urinary devices and implants	0.002	0.998	0.000
K26.4 Chronic or unspecified with haemorrhage	0.002	0.998	0.000
R49.0 Dysphonia	0.000	0.998	0.002
T51.9 Alcohol, unspecified	0.001	0.998	0.000
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)	0.000	0.998	0.001
F31.6 Bipolar affective disorder, current episode mixed	0.001	0.998	0.000
F62.9 Enduring personality change, unspecified	0.001	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations